Publications:

Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy.

Cell Research

Mugoni, Vera V; Panella, Riccardo R; Cheloni, Giulia G; Chen, Ming M; Pozdnyakova, Olga O; Stroopinsky, Dina D; Guarnerio, Jlenia J; Monteleone, Emanuele E; Lee, Jonathan David JD; Mendez, Lourdes L; Menon, Archita Venugopal AV; Aster, Jon Christopher JC; Lane, Andrew A AA; Stone, Richard Maury RM; Galinsky, Ilene I; Zamora, José Cervera JC; Lo-Coco, Francesco F; Bhasin, Manoj Kumar MK; Avigan, David D; Longo, Letizia L; Clohessy, John Gerard JG; Pandolfi, Pier Paolo PP

Publication Date: 2019-06

Variant appearance in text: RARA: C203G

PubMed Link: 31024166

Variant Present in the following documents:

• Main text

View BVdb publication page